NCT06850831View on ClinicalTrials.gov

Effect of Intracoronary N-Acetylcysteine in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

June 30, 2025

Study Completion Date

August 31, 2025

Conditions
STEMI - ST Elevation Myocardial Infarction (MI)Primary PCI - STEMI
Interventions
DRUG

Antipac

The first group is the NAC group, which will get intracoronary NAC 480 mg immediately after the lesion is opened during primary PCI. And the second group will have placebo immediately after the lesion is opened during primary PCI.

Trial Locations (1)

57126

Dr. Moewardi General Hospital, Surakarta

All Listed Sponsors
lead

dr. Ahmad Yasa, Sp.JP, Subsp.K.I.(K), M.Kes, FIHA, FasCC, FA

OTHER